0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Androgen Receptor (AR) Antagonist Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-29W17150
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Androgen Receptor AR Antagonist Market Research Report 2024
BUY CHAPTERS

Global Androgen Receptor (AR) Antagonist Market Research Report 2024

Code: QYRE-Auto-29W17150
Report
June 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Androgen Receptor (AR) Antagonist Market

Androgen receptor (AR) antagonists are a class of drugs that bind to androgen receptors, thereby preventing or reducing the biological effects of androgens.
The global Androgen Receptor (AR) Antagonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Androgen Receptor (AR) Antagonist is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Androgen Receptor (AR) Antagonist is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Androgen Receptor (AR) Antagonist include R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Androgen Receptor (AR) Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Receptor (AR) Antagonist.
The Androgen Receptor (AR) Antagonist market size, estimations, and forecasts are provided in terms of sales volume (Kilotons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Androgen Receptor (AR) Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Androgen Receptor (AR) Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Androgen Receptor (AR) Antagonist Market Report

Report Metric Details
Report Name Androgen Receptor (AR) Antagonist Market
Segment by Type
  • Steroidal AR Antagonists
  • Nonsteroidal AR Antagonists
Segment by Application
  • Prostate Cancer
  • Breast Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Androgen Receptor (AR) Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Androgen Receptor (AR) Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Androgen Receptor (AR) Antagonist Market report?

Ans: The main players in the Androgen Receptor (AR) Antagonist Market are R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine

What are the Application segmentation covered in the Androgen Receptor (AR) Antagonist Market report?

Ans: The Applications covered in the Androgen Receptor (AR) Antagonist Market report are Prostate Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Androgen Receptor (AR) Antagonist Market report?

Ans: The Types covered in the Androgen Receptor (AR) Antagonist Market report are Steroidal AR Antagonists, Nonsteroidal AR Antagonists

1 Androgen Receptor (AR) Antagonist Market Overview
1.1 Product Definition
1.2 Androgen Receptor (AR) Antagonist by Type
1.2.1 Global Androgen Receptor (AR) Antagonist Market Value Comparison by Type (2024-2030)
1.2.2 Steroidal AR Antagonists
1.2.3 Nonsteroidal AR Antagonists
1.3 Androgen Receptor (AR) Antagonist by Application
1.3.1 Global Androgen Receptor (AR) Antagonist Market Value by Application (2024-2030)
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Global Androgen Receptor (AR) Antagonist Market Size Estimates and Forecasts
1.4.1 Global Androgen Receptor (AR) Antagonist Revenue 2019-2030
1.4.2 Global Androgen Receptor (AR) Antagonist Sales 2019-2030
1.4.3 Global Androgen Receptor (AR) Antagonist Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Androgen Receptor (AR) Antagonist Market Competition by Manufacturers
2.1 Global Androgen Receptor (AR) Antagonist Sales Market Share by Manufacturers (2019-2024)
2.2 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Androgen Receptor (AR) Antagonist Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Androgen Receptor (AR) Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Product Type & Application
2.7 Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Date of Enter into This Industry
2.8 Global Androgen Receptor (AR) Antagonist Market Competitive Situation and Trends
2.8.1 Global Androgen Receptor (AR) Antagonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Androgen Receptor (AR) Antagonist Players Market Share by Revenue
2.8.3 Global Androgen Receptor (AR) Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Androgen Receptor (AR) Antagonist Market Scenario by Region
3.1 Global Androgen Receptor (AR) Antagonist Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Androgen Receptor (AR) Antagonist Sales by Region: 2019-2030
3.2.1 Global Androgen Receptor (AR) Antagonist Sales by Region: 2019-2024
3.2.2 Global Androgen Receptor (AR) Antagonist Sales by Region: 2025-2030
3.3 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2019-2030
3.3.1 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2019-2024
3.3.2 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2025-2030
3.4 North America Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.4.1 North America Androgen Receptor (AR) Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Androgen Receptor (AR) Antagonist Sales by Country (2019-2030)
3.4.3 North America Androgen Receptor (AR) Antagonist Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.5.1 Europe Androgen Receptor (AR) Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Androgen Receptor (AR) Antagonist Sales by Country (2019-2030)
3.5.3 Europe Androgen Receptor (AR) Antagonist Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Androgen Receptor (AR) Antagonist Market Facts & Figures by Region
3.6.1 Asia Pacific Androgen Receptor (AR) Antagonist Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Androgen Receptor (AR) Antagonist Sales by Region (2019-2030)
3.6.3 Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.7.1 Latin America Androgen Receptor (AR) Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Androgen Receptor (AR) Antagonist Sales by Country (2019-2030)
3.7.3 Latin America Androgen Receptor (AR) Antagonist Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa Androgen Receptor (AR) Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2019-2030)
3.8.3 Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Androgen Receptor (AR) Antagonist Sales by Type (2019-2030)
4.1.1 Global Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
4.1.2 Global Androgen Receptor (AR) Antagonist Sales by Type (2025-2030)
4.1.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2030)
4.2 Global Androgen Receptor (AR) Antagonist Revenue by Type (2019-2030)
4.2.1 Global Androgen Receptor (AR) Antagonist Revenue by Type (2019-2024)
4.2.2 Global Androgen Receptor (AR) Antagonist Revenue by Type (2025-2030)
4.2.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2019-2030)
4.3 Global Androgen Receptor (AR) Antagonist Price by Type (2019-2030)
5 Segment by Application
5.1 Global Androgen Receptor (AR) Antagonist Sales by Application (2019-2030)
5.1.1 Global Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
5.1.2 Global Androgen Receptor (AR) Antagonist Sales by Application (2025-2030)
5.1.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2030)
5.2 Global Androgen Receptor (AR) Antagonist Revenue by Application (2019-2030)
5.2.1 Global Androgen Receptor (AR) Antagonist Revenue by Application (2019-2024)
5.2.2 Global Androgen Receptor (AR) Antagonist Revenue by Application (2025-2030)
5.2.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2019-2030)
5.3 Global Androgen Receptor (AR) Antagonist Price by Application (2019-2030)
6 Key Companies Profiled
6.1 R&D Systems
6.1.1 R&D Systems Company Information
6.1.2 R&D Systems Description and Business Overview
6.1.3 R&D Systems Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.1.4 R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio
6.1.5 R&D Systems Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Androgen Receptor (AR) Antagonist Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Janssen Pharmaceuticals
6.3.1 Janssen Pharmaceuticals Company Information
6.3.2 Janssen Pharmaceuticals Description and Business Overview
6.3.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio
6.3.5 Janssen Pharmaceuticals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Androgen Receptor (AR) Antagonist Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Astellas Pharma
6.5.1 Astellas Pharma Company Information
6.5.2 Astellas Pharma Description and Business Overview
6.5.3 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio
6.5.5 Astellas Pharma Recent Developments/Updates
6.6 Kaituo Pharmaceutical
6.6.1 Kaituo Pharmaceutical Company Information
6.6.2 Kaituo Pharmaceutical Description and Business Overview
6.6.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio
6.6.5 Kaituo Pharmaceutical Recent Developments/Updates
6.7 Hengrui Medicine
6.7.1 Hengrui Medicine Company Information
6.7.2 Hengrui Medicine Description and Business Overview
6.7.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio
6.7.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Androgen Receptor (AR) Antagonist Industry Chain Analysis
7.2 Androgen Receptor (AR) Antagonist Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Androgen Receptor (AR) Antagonist Production Mode & Process
7.4 Androgen Receptor (AR) Antagonist Sales and Marketing
7.4.1 Androgen Receptor (AR) Antagonist Sales Channels
7.4.2 Androgen Receptor (AR) Antagonist Distributors
7.5 Androgen Receptor (AR) Antagonist Customers
8 Androgen Receptor (AR) Antagonist Market Dynamics
8.1 Androgen Receptor (AR) Antagonist Industry Trends
8.2 Androgen Receptor (AR) Antagonist Market Drivers
8.3 Androgen Receptor (AR) Antagonist Market Challenges
8.4 Androgen Receptor (AR) Antagonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Androgen Receptor (AR) Antagonist Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Androgen Receptor (AR) Antagonist Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Androgen Receptor (AR) Antagonist Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) of Key Manufacturers (2019-2024)
 Table 5. Global Androgen Receptor (AR) Antagonist Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Androgen Receptor (AR) Antagonist Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Androgen Receptor (AR) Antagonist Average Price (US$/Ton) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Androgen Receptor (AR) Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Product Type & Application
 Table 12. Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Androgen Receptor (AR) Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Receptor (AR) Antagonist as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Androgen Receptor (AR) Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Androgen Receptor (AR) Antagonist Sales by Region (2019-2024) & (Kilotons)
 Table 18. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2019-2024)
 Table 19. Global Androgen Receptor (AR) Antagonist Sales by Region (2025-2030) & (Kilotons)
 Table 20. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2025-2030)
 Table 21. Global Androgen Receptor (AR) Antagonist Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2019-2024)
 Table 23. Global Androgen Receptor (AR) Antagonist Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2025-2030)
 Table 25. North America Androgen Receptor (AR) Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
 Table 27. North America Androgen Receptor (AR) Antagonist Sales by Country (2025-2030) & (Kilotons)
 Table 28. North America Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Androgen Receptor (AR) Antagonist Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Androgen Receptor (AR) Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
 Table 32. Europe Androgen Receptor (AR) Antagonist Sales by Country (2025-2030) & (Kilotons)
 Table 33. Europe Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Androgen Receptor (AR) Antagonist Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Androgen Receptor (AR) Antagonist Sales by Region (2019-2024) & (Kilotons)
 Table 37. Asia Pacific Androgen Receptor (AR) Antagonist Sales by Region (2025-2030) & (Kilotons)
 Table 38. Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Androgen Receptor (AR) Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
 Table 42. Latin America Androgen Receptor (AR) Antagonist Sales by Country (2025-2030) & (Kilotons)
 Table 43. Latin America Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
 Table 47. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2025-2030) & (Kilotons)
 Table 48. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Type (2019-2024)
 Table 51. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Type (2025-2030)
 Table 52. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
 Table 53. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2025-2030)
 Table 54. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2019-2024)
 Table 57. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2025-2030)
 Table 58. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Type (2019-2024)
 Table 59. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Type (2025-2030)
 Table 60. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Application (2019-2024)
 Table 61. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Application (2025-2030)
 Table 62. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
 Table 63. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2025-2030)
 Table 64. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2019-2024)
 Table 67. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2025-2030)
 Table 68. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Application (2019-2024)
 Table 69. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Application (2025-2030)
 Table 70. R&D Systems Company Information
 Table 71. R&D Systems Description and Business Overview
 Table 72. R&D Systems Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 73. R&D Systems Androgen Receptor (AR) Antagonist Product
 Table 74. R&D Systems Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 78. Bayer Androgen Receptor (AR) Antagonist Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Janssen Pharmaceuticals Company Information
 Table 81. Janssen Pharmaceuticals Description and Business Overview
 Table 82. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 83. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product
 Table 84. Janssen Pharmaceuticals Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 88. Pfizer Androgen Receptor (AR) Antagonist Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Astellas Pharma Company Information
 Table 91. Astellas Pharma Description and Business Overview
 Table 92. Astellas Pharma Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 93. Astellas Pharma Androgen Receptor (AR) Antagonist Product
 Table 94. Astellas Pharma Recent Developments/Updates
 Table 95. Kaituo Pharmaceutical Company Information
 Table 96. Kaituo Pharmaceutical Description and Business Overview
 Table 97. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 98. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product
 Table 99. Kaituo Pharmaceutical Recent Developments/Updates
 Table 100. Hengrui Medicine Company Information
 Table 101. Hengrui Medicine Description and Business Overview
 Table 102. Hengrui Medicine Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 103. Hengrui Medicine Androgen Receptor (AR) Antagonist Product
 Table 104. Hengrui Medicine Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Androgen Receptor (AR) Antagonist Distributors List
 Table 108. Androgen Receptor (AR) Antagonist Customers List
 Table 109. Androgen Receptor (AR) Antagonist Market Trends
 Table 110. Androgen Receptor (AR) Antagonist Market Drivers
 Table 111. Androgen Receptor (AR) Antagonist Market Challenges
 Table 112. Androgen Receptor (AR) Antagonist Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Androgen Receptor (AR) Antagonist
 Figure 2. Global Androgen Receptor (AR) Antagonist Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Androgen Receptor (AR) Antagonist Market Share by Type: 2023 & 2030
 Figure 4. Steroidal AR Antagonists Product Picture
 Figure 5. Nonsteroidal AR Antagonists Product Picture
 Figure 6. Global Androgen Receptor (AR) Antagonist Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Androgen Receptor (AR) Antagonist Market Share by Application: 2023 & 2030
 Figure 8. Prostate Cancer
 Figure 9. Breast Cancer
 Figure 10. Others
 Figure 11. Global Androgen Receptor (AR) Antagonist Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Androgen Receptor (AR) Antagonist Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Androgen Receptor (AR) Antagonist Sales (2019-2030) & (Kilotons)
 Figure 14. Global Androgen Receptor (AR) Antagonist Average Price (US$/Ton) & (2019-2030)
 Figure 15. Androgen Receptor (AR) Antagonist Report Years Considered
 Figure 16. Androgen Receptor (AR) Antagonist Sales Share by Manufacturers in 2023
 Figure 17. Global Androgen Receptor (AR) Antagonist Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Androgen Receptor (AR) Antagonist Players: Market Share by Revenue in Androgen Receptor (AR) Antagonist in 2023
 Figure 19. Androgen Receptor (AR) Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Androgen Receptor (AR) Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2030)
 Figure 22. North America Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2030)
 Figure 23. United States Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2030)
 Figure 26. Europe Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Androgen Receptor (AR) Antagonist Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2019-2030)
 Figure 34. China Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Androgen Receptor (AR) Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Androgen Receptor (AR) Antagonist by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Androgen Receptor (AR) Antagonist by Type (2019-2030)
 Figure 53. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Androgen Receptor (AR) Antagonist by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Androgen Receptor (AR) Antagonist by Application (2019-2030)
 Figure 56. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Application (2019-2030)
 Figure 57. Androgen Receptor (AR) Antagonist Value Chain
 Figure 58. Androgen Receptor (AR) Antagonist Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart